FibroGen
Monique Mackey has over 20 years of experience in executive support and business operations, currently serving as a Senior Coordinator at FibroGen, Inc. since June 2015, where responsibilities include providing executive support to the Senior Vice President of CMC and overseeing team operations. Previous roles at FibroGen included an Administrative Assistant position in Pharmaceutical Development and Manufacturing and a contract role as Interim Travel and Expense Administrator. Prior to FibroGen, Monique held executive assistant positions at First Republic Bank, assisting Senior Vice Presidents in Business Banking and Credit Administration, contributing to team growth, and managing communications. Monique’s career began with various executive support roles prior to 2001, and educational credentials include a Bachelor of Science in Psychology from Fordham University.
This person is not in any teams
FibroGen
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the Company's most advanced product candidate, is an oral small molecule inhibitor of HIF prolyl hydroxylase activity in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and is entering Phase III development for anemia in lower risk myelodysplastic syndromes (MDS). The Company has developed Pamrevlumab. Pamrevlumab is a proprietary therapeutic antibody to inhibit the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure.